Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall tone indicates strong agreement with the importance of AI in improving prostate cancer detection, exemplified by phrases such as 'AI-powered screening' and 'automated platform,' which reflect enthusiasm and recognition of technological potential. Interest is demonstrated through specific mentions of clinical examinations, machine learning, and multimodal data, showing that the discussions are not superficial but rather detail-oriented and motivated by potential impact.
Most discussions express strong support or positive outlooks toward the study’s advancements in AI for prostate cancer diagnosis.
The posts show high interest, with numerous mentions of the potential benefits and technical aspects of the research.
Some posts delve into details about the methodology and implications, indicating a moderate level of engagement.
Comments largely suggest that the study could have meaningful effects on diagnostic processes and healthcare practices.
#Artificialintelligence for the diagnosis of clinically significant #prostate #cancer based on multimodal data: a multicenter study https://t.co/XY4W8TXNFb
In this study, Huiyong Zhang et al. present a new tool to improve the detection of clinically significant #prostatecancer based on routinely performed clinical examinations through an automated #MachineLearning platform #AutoML #cancer Read it here: https://t.co/ivBYQ1cU6Y https://t.co/KjTnH3sOQA
#ArtificialIntelligence for the diagnosis of clinically significant #prostateCancer based on multimodal #data: a multicenter study #AI #ML #MachineLearning #DeepLearning #DL #Tech #Algorithm #Data #HealthCare #HealthTech #MedicalTech #MedTech https://t.co/ZMD6QelPHH https://t.co/VkMCGO63uM
'Artificial intelligence for the diagnosis of clinically significant prostate cancer based on multimodal data: a multicenter study' https://t.co/nAyYWBjVUf #prostatecancer #AI https://t.co/N6k06EDg06
Inaccurate tests (e.g., PSA, mammography) cannot be cost-effective. AI powered prostate cancer screening is associated with avoided unnecessary biopsies https://t.co/VjJsFyMJX4 https://t.co/9PEQyWW6gE
'Artificial intelligence for the diagnosis of clinically significant prostate cancer based on multimodal data: a multicenter study' https://t.co/F17UDm41H4 #prostatecancer #AI https://t.co/sy47PetUtA
This video discusses the use of artificial intelligence and machine learning techniques for diagnosing clinically significant prostate cancer using multimodal data, based on a multicenter study. It highlights…
Inaccurate tests (e.g., PSA, mammography) cannot be cost-effective. AI powered prostate cancer screening is associated with avoided unnecessary biopsies https://t.co/VjJsFyMJX4 https://t.co/9PEQyWW6gE
In this study, Huiyong Zhang et al. present a new tool to improve the detection of clinically significant #prostatecancer based on routinely performed clinical examinations through an automated #MachineLearning platform #AutoML #cancer Read it here: https://t.co/ivBYQ1cU6Y https://t.co/KjTnH3sOQA
#ArtificialIntelligence for the diagnosis of clinically significant #prostateCancer based on multimodal #data: a multicenter study #AI #ML #MachineLearning #DeepLearning #DL #Tech #Algorithm #Data #HealthCare #HealthTech #MedicalTech #MedTech https://t.co/ZMD6QelPHH https://t.co/VkMCGO63uM
#Artificialintelligence for the diagnosis of clinically significant #prostate #cancer based on multimodal data: a multicenter study https://t.co/XY4W8TXNFb
'Artificial intelligence for the diagnosis of clinically significant prostate cancer based on multimodal data: a multicenter study' https://t.co/nAyYWBjVUf #prostatecancer #AI https://t.co/N6k06EDg06
'Artificial intelligence for the diagnosis of clinically significant prostate cancer based on multimodal data: a multicenter study' https://t.co/F17UDm41H4 #prostatecancer #AI https://t.co/sy47PetUtA